INEX INNOVATE PTE. LTD.
Last Updated: 13 Apr 2026
Entrepreneur-led and science-backed, INEX is one of Asia's fastest growing molecular diagnostics developers and medical laboratory operators. Founded by veteran maternal fetal medicine specialists, INEX identifies and addresses clinically unmet needs in fetal health and women's oncology with a broad commercial portfolio of validated tests and 49 key patents. Through its wholly owned subsidiary iGene Laboratory Pte Ltd, INEX operates a state-of-the-art Next Generation Sequencing Laboratory providing diagnostic testing, clinical research, and infectious testing services. Recognized globally with numerous accolades and awards, INEX is committed to advancing healthcare through innovative diagnostics and personalized medicine.
Country of registration | Singapore |
Registration number | 200609260M |
Local SIC | |
Incorporation date | 24 Jun 2006 |
Company age | 19 years 11 months |
Official entity type | Private Limited Company |
No. of officers | 38 |
Contact
Address:
1 SCIENCE PARK ROAD, #04-10, THE CAPRICORN, Singapore 117528
Access Key Decision Makers
This is the legal entity page of INEX INNOVATE PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- INEX INNOVATEView MoreSingaporeEntrepreneur-led and science-backed, INEX is one of Asia's fastest growing molecular diagnostics developers and medical laboratory operators. Founded by veteran maternal fetal medicine specialists, INEX identifies and addresses clinically unmet needs in fetal health and women's oncology with a broad commercial portfolio of validated tests and 49 key patents. Through its wholly owned subsidiary iGene Laboratory Pte Ltd, INEX operates a state-of-the-art Next Generation Sequencing Laboratory providing diagnostic testing, clinical research, and infectious testing services. Recognized globally with numerous accolades and awards, INEX is committed to advancing healthcare through innovative diagnostics and personalized medicine.
This is the legal entity page of INEX INNOVATE PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Fiscal/Budgeting Period | October - December |
Auditor | ERNST & YOUNG LLP |
Revenue | 26m - 50m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | USD 12,000,807 |
Share Capital - Ordinary shares | SGD 7,076,973 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of INEX INNOVATE PTE. LTD.?
- Where is INEX INNOVATE PTE. LTD.'s headquarter?
- What is INEX INNOVATE PTE. LTD.'s contact number?
- What INEX INNOVATE PTE. LTD.'s spending power?
- Does INEX INNOVATE PTE. LTD. have a presence in the domain it operates in?